跳到正文
原文
The Lancet 柳叶刀· Michael D Jenkinson, Anna Rosala-Hallas, Felix Sahm, Nicolaus Andratschke, Keyoumars Ashkan, Damiano Balestrini, Helen Bulbeck, Sílvia Comas, Giovanna Culeddu, Kumar Das, Laura Fariselli, Karen Foweraker, Priya Francis, Efstathia Gkioni, Vassilis Golfinopoulos, Thierry Gorlia, Neda Haghighi, Brian J Haylock, Dyfrig A Hughes, Mohsen Javadpour, Philippe Martinive, Helen M O Mayles, Perry Moore, Emilie Le Rhun, Nicola Rosenfelder, Gail Ryan, Michael Weller, Carrol Gamble, Matthias Preusser, Damien C Weber, ROAM/1308 Study Collaborators·· 2026-09-25精选AI 评分63

ROAM/EORTC-1308 III 期随机对照试验比较 WHO 2 级非典型脑膜瘤完全切除后辅助放疗与观察

[Articles] Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial

AI 导读

ROAM/EORTC-1308 是一项国际多中心、开放标签 III 期随机对照试验,比较 WHO 2 级非典型脑膜瘤完全手术切除后辅助放疗与观察。研究团队认为,辅助放疗可减少脑膜瘤复发,当预防复发较放疗可能的迟发不良反应更被看重时应考虑放疗,具体决策需与患者个体讨论。

推荐理由

III 期随机对照试验结果提示完全切除后辅助放疗可减少非典型脑膜瘤复发,为术后是否放疗的决策提供依据。

来源:The Lancet 柳叶刀 · thelancet.com